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Abstract. The ability of the myogenic determination
gene (MyoDl) to convert differentiating human kerati-
nocytes (HaCaT cell-line) to the myogenic pathway
and the effect of MyoD1 on the epidermal phenotype
was studied in culture and in surface transplants on
nude mice. MyoD1 transfection induced the synthesis
of myosin, desmin, and vimentin without substantially
altering the epidermal differentiation properties (mor-
phology, keratin profile) in vitro nor epidermal mor-
phogenesis (formation of a complex stratified squamous
epithelium) in surface transplants, demonstrating the
stability of the keratinocyte phenotype. 5Aza-CdR
treatment of these MyoDl-transfected cells had little
effect on the cultured cells but a morphologically un-
structured epithelium was formed with no indications
of typical cell layers including cornification. Since
prevention of epidermal strata in transplants was not
accompanied by blocked epidermal differentiation mark-
D
URING embryogenesis the epidermis develops from a
two-layered to a complex-stratified squamous epi-
thelium. As the cells migrate from the basal prolif
erative zone they pass through an ordered sequence of de-
fined morphological changes (histodifferentiation), leading
to the formation of distinct strata. Concomitantly, specific
differentiation products are sequentially expressed and these
serve as excellent markers to determine the respective state
of differentiation in experimental models. As part ofthis dif-
ferentiation program, the synthesis of a number of proteins
is induced including keratins, involucrin, and filaggrin. The
keratins are the most abundant proteins in the keratinocytes
and the position of a cell in the differentiation sequence is
reflected by the composition of these intermediate filaments
(Fuchs and Green, 1980; Moll et al., 1982a; Skerrow and
Skerrow, 1983 ; Sun et al., 1983 ; Bowden et al., 1987) .
Poly- and monoclonal antibodies are available that are highly
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ers (keratins Kl and K10, involucrin, and filaggrin),
the dissociation of morphogenesis and expression of
these markers argues for independently controlled
processes. A subpopulation of less adhesive cells, iso-
lated from the 5-aza-CdR treated MyoDI-transfectants,
had lost most epithelial characteristics in culture (epi-
dermal keratins, desmosomal proteins, and surface-
glycoprotein Gp90) and had shifted to a mesenchymal/
myogenic phenotype (fibroblastic morphology, trans-
activation of Myf3 and myogenin, expression of myo-
sin, desmin, vimentin, and Gp130) . Moreover, the
cells had lost the ability to stratify and remained as a
monolayer of flat elongated cells in transplants. These
subsequent changes from a fully differentiated keratino-
cyte to a mesenchymal/myogenic phenotype strongly
argue for a complex "transdifferentiation" process
which occurred in the original monoclonal human
epidermal HaCaT cells.
specific for the respective keratins and thus label discrete
compartments, allowing for the evaluation of the status of
differentiation. Involucrin, a precursor of the cornified enve-
lopes in the outermost epidermal layers, marks a later stage
in epidermal differentiation (Riceand Green, 1979; Watt and
Green, 1981) . Similarly, filaggrin, the major matrix compo-
nent of the keratohyalin granules appears in the stratum
granulosum, the zone before the keratinocytes lose cell or-
ganelles and become dead horn-squames (Daleet al., 1978 ;
Scott and Harding, 1981).
Many details are known for the identification ofthe epider-
mal differentiation process and the different components are
well characterized. Little, however, is known aboutthe genes
responsible for the ordered sequence of expression of the
different markers and thus the regulation of differentiation.
In myogenesis, on the other hand, four such genes have been
described. These are MyoDI (Davis et al., 1987), myogenin
1257(Wright et al., 1989), Myf5 (Braun et al., 1989), and Mrf4
(Rhodes and Konieczny, 1989), also known as herculin
(Miner and Wold, 1990), and Myf6 (Braun et al ., 1990).
These genes, when transfected into a number of nonmyo-
genic cell types, can convert them into stable myogenic
clones which then express reporter genes normally inactive
in these cells (for review see Olson, 1990). Certain cells of
epithelial origin, such as HeLa or HepG2, appear to be
refractory to myogenic conversion (Weintraub et al., 1989;
Schäfer et al., 1990) and it has been hypothesized that the
failure ofMyoD1 to activate myogenesis in these cases is due
to negative factors present in some cell types or that factors
with which MyoD1 cooperates are not ubiquitous (Olson,
1990) . Alternatively, myogenic conversion of nonmesen-
chymal cellsmight be dependent on their continued capacity
to differentiate, i .e., only those cells would be able to re-
spond in which genes required to regulate and express
differentiation (including the expression of "ubiquitous" fac-
tors) are active. The latter hypothesis is largely substantiated
by fusion experiments of a mouse muscle cell line with a
number of human nonmuscle cells including normal ker-
atinocytes and Hela cells (Blau et al., 1985) . While in all het-
erokaryons with normal cells human muscle geneswere acti-
vated heterokaryons with HeLa cells failed to express the
human muscle markers analyzed. Accordingly, HeLa cells
that are unable to differentiate in vitro or in vivo (our own
unpublished observations) could also not be induced to ex-
press myogenic differentiation products after transfection
with the MyoD1 gene (Weintraub et al., 1989). Thus, differ-
entiation-related genes are possibly inactive in these cells
and therefore not accessible for cooperation with the MyoD1
gene. However, these genes could obviously be reactivated
after treatment with 5-azacytidine, a drug thought to reduce
gene methylation (Blau et al., 1985).
Our interest is focused on human skin keratinocytes and
respective cell lines that have maintained a high potential for
epidermal differentiation. These cells provide excellent
models to study the degree to which the authentic phenotype
is maintained since, as stated above, epidermal differentia-
tion is well characterized and a number ofmarkers are avail-
able. We recently described the establishment of a spontane-
ously immortalized cell line (HaCaT) from human skin
keratinocytes that is nontumorigenic and has largely retained
the normal epidermal phenotype (Boukamp et al., 1988;
Ryle et al., 1989). Manipulations, potentially able to alter
epidermal differentiation, such as transfection and expres-
sion of the c-Ha-ras oncogene or malignant conversion, did
not interfere substantially with its differentiation capacity
(Boukamp et al., 1990b; Breitkreutz et al ., 1991) . This sug-
gests that epidermal differentiation is a stable trait of these
cells.
The HaCaT cells were used as a model of differentiating
human keratinocytes to ask whether transfection of a single
myogenic determination gene, the MyoDl gene, can simi-
larly induce myogenic differentiation in a cell of ectodermal
linage as seen in heterokaryons. Hereby our intention was fo-
cusedon analyzing a broad spectrum ofepidermal differenti-
ation markers since, to our knowledge, the interference of
such foreign regulatory genes with the inherent epidermal
differentiation program has not been studied extensively.
Moreover, since epidermal differentiation, including mor-
phogenesis (formation of a structured epidermis), remains
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incomplete under conventional culture conditions in vitro
(Holbrook and Hennings,1983 ; Breitkreutz et al., 1984), we
additionally analyzed the transfectants under more physio-
logical conditions in vivo (in surface transplants: Fusenig et
al., 1983; Boukamp et al., 1985, 1990a) where normal ker-
atinocytes and also the immortal HaCaT cells form a well
structured and normally differentiated epidermis-like sur-
face epithelium within one to two weeks (Boukamp et al.,
1988, 1990a) .Thus, the in vivo assay was particularly useful
in allowing us to determine the influence of MyoDl on tissue
organization in addition to the expression of differentiation
markers.
Materials andMethods
Scheme of evolution of cell variants and associated phenotypic changes:
Cell Cultures
The HaCaT cells were routinely grown in modified MEM (Fusenig and
Worst, 1975) supplemented with 10% FCS and antibiotics at 37°C, 5%
CO2, and 95% air in a humidified incubator as described previously (Bou-
kamp et al., 1988). The cells were passaged once a week at a split ratio
of 1:10 and the medium was changed twice a week. For immunofluores-
cence, the cells were seeded on glass cover slips and either fixed when still
subconfluent or after an additional 2-8 wk after confluency.
Tlransfection ofCells
HaCaT cells were transfected as described previously (Chen and Jones,
1990) using a calciumphosphate precipitate of 20 Ecg pEMSV scribe DNA
or 20kg pEMSVMyoD1 DNA togetherwith 2 ugpNeo3, aplasmidconfer-
ring resistance to the neomycin derivative G418. Selection in medium con-
taining 400 Icg G418/ml was started 48 h later. G418 resistant stable trans-
fectants were ring isolated and maintained under continued selection.
5-aza-CdR Tlreatment
Cells (104/60-mm dish, Falcon Labware, Oxnard, CA) were treated with 5
AM 5-aza-2'-deoxycytidine (5-aza-CdR; Sigma Chemical Co., St. Louis,
MO and München, Germany) 24 h after seeding. The drug was removed
24 h later by replacing it with fresh drug-free medium. Morphological
changes were first apparent N5 wk after treatment.
Southern BlotAnalysis
DNA was extracted as described previously (Chen and Jones, 1990),
digested with EcoRI (Boehringer Mannheim GmbH, Mannheim, Ger-
many), run on a 1% agarose gel and transferred to Zetaprobe membrane
(Cuno Inc., Meriden, CT) following the manufacturer's protocols. The
mouse MyoDI 1.8-kb fragment was 31P labeled using the procedure de-
scribed by Feinberg and Vogelstein (1984). Hybridization was done using
1258
HaCaT epidermal phenotype
MyoDI
transfection
clone-13 induction of myosin, desmin
and vimentin
5-aza-cytidine
treatment
clone-13aza loss of tissue organization
(histodifferentiation)
differential
trypsinization
DTHMZ loss of epidermal growth and
differentiation characteristicsthe protocol of Church and Gilbert (1984). The blots were exposed to film
(XAR; Eastman Kodak Co., Rochester, NY) for 1-7 d at -70"C.
Northern BlotAnalysis
Total mRNA was isolated from cells lysedin 7.6 M guanidinehydrochloride
(Cheley and Anderson, 1984), 20 i~g ofRNA sampleswere electrophoresed
on 1% agarose, MOPS-2.2 M formaldehyde gels (Lehrach et al., 1977),
transferred onto Zetaprobe membranes in 10x SSC (1.5 M sodium chlo-
ride, 0.15 M sodium citrate), UV cross-linkedtothe membrane, andhybrid-
ized as above.
Transplantation
Organotypic cultures were prepared as described previously (Boukamp et
al ., 1990x). Briefly, collagengels (4 mg/ml) ofrat tail collagen (type I) were
mounted in Combi-ring dishes (Renner KG, Dannstadt, Germany) (Nosey
and Limat, 1987) and 2 x 105 cells were seeded onto the collagen surface.
After x+17 h the medium covering the cells was drained and the collagen
chamber was covered with a hat-like transplantation chamber (Renner KG) .
The whole unit was then transplanted onto the muscle fascia of the back
of nude mice, as described (Boukamp et al., 1985, 1990x). Transplants
were excised "en bloc"atdays 4, 8, 12, 17, and27 and either fixed inbuffered
formalin for histology or embedded in Tissue Tec (Lab-Tec. Div., Miles
Laboratories Inc., Naperville, IL) and snap frozen in liquid nitrogen pre-
cooled isopentane and stored in liquid nitrogen for cryostat sections.
Indirect Immunofuorescence
Cells grown on glass coverslips were washed in PBS (3 x 5 min) before
being fixed by serial immersion (5 min each) in 50, 100, and 50% acetone.
After air drying the cells were rehydrated (10 min in PBS) and incubated
with antibody solutions for 45 min in a moist chamber at room temperature.
Antibodies used were: mouse mAbs against the differentiation-specific ker-
atins Kl and K10 (Renner KG), the basal keratin 14 (kindly provided by Dr.
E. Leigh); "simple epithelia" keratins K7, K8, K18, and K19 (Amersham
Corp., Braunschweig, Germany); myosin (MF-20, Bader et al., 1982; a gift
from Dr. D. Fishman); desmin (Dianova, Hamburg, Germany); the des-
mosomal proteins desmoplakin, plakoglobin, and desmoglein (Progen,
Heidelberg, Germany); and cell surface glycoproteins GP90 and GP130
(kindly provided by Dr. E. Klein). A po1ycloua1 rabbit antibody against
MyoDl was generously supplied by Dr. A. Lassar. For staining ofthe latter
three the cells were fixed with 3.7% formaldehyde (in PBS) for 20 min fol-
lowed by 10 min in -20"C methanol. The coverslips were washed in PBS
(3 x 5 min) and incubated for an additional 45 min with an anti-mouse,
anti-rabbit, or anti-guinea pig gamma globulin coupled to fluorescein-
isothiocyanate (FITC) (Dianova, Hamburg, Germany), respectively. After
another wash of 3 x 5 min, and a final rinse in 10 mM Tris-HCI buffer
(pH 8.5), thecoverslips were mounted onto slides with Aqua mount (Lerner
Laboratories, New Haven, CT) and viewed under an inverted microscope
(model IM 35; Carl Zeiss, Inc., Thornwood, NY) equipped with epifluores-
cence optics.
For double inununofluorescence, a guinea pig anti-pankeratin (kindly
provided by Dr. G. Bruder, Progen, Heidelberg, Germany) and a mouse
mAb against vimentin (Progen) were used. The first antibodies were incu-
bated overnight at room temperature, followed by a 1-h incubation with
guinea pig anti-biotin and a 1-h incubation with a mixture ofTexas red cou-
pled to streptavidine and anti-mouse FITC. Similarly, 57-Am air-dried sec-
tions were rehydrated and the unfixed sections were treated as described
above using a sequence specific antibody against Kl, raised in guinea pig
(Roopet al., 1984; kindly providedbyDr. D. Roop, Baylor College ofMedi-
cine, Houston, TX), a rabbit antisera againsthuman involucrin(Watt, 1984;
a gift from Dr. F. Watt), and a mAb against filaggrin (Paesel, Frankfurt,
Germany).
Results
Stable TransfectionofHaCaTCells with
MouseMyoD1
The human epidermal HaCaT cells were transfected with a
plasmid containing the mouse MyoD1 gene, driven by the
Moloney sarcoma virus promoter, and the neomycin resis-
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tance gene to determine the influence of MyoD1 on the
epidermal phenotype. Cultures transfected with the plasmid
without the MyoDI insert were used as controls. Herein, the
differentiation behavior of a clone transfected with the plas-
mid containing the MyoDI gene insert (clone-13) and a con-
trol clone (Vec-2 ; missing the MyoDI insert) are mostly de-
scribed in detail but all data were confirmed with a second
independent set of clones (clone-6 and Vec-1).
Southern analyses were performed to confirm stable in-
tegration ofthe MyoD1 gene (Fig. 1 A). DNA extracted from
HaCaT, Vec-2-, and MyoDI-transfected clone-6 and clone-
13 cells was digested with EcoRI to release the 1.8-kb
MyoD1 cDNA insert. The 1.8-kb signal was absent in the pa-
rental HaCaT and Vec-2 cellsbut was present in clone-6 and
clone-13 cells. Several high molecular weight bands were ad-
ditionally visible for clone-13. These are most likely because
of rearrangements that occurred during integration of the
DNA into the host genome. In addition, a 6.8-kb fragment
was present in all cells, representing the human homolog
(Myf3; Braun et al., 1990) of the mouse MyoD1 gene that
cohybridized under the hybridization stringencies used.
Expression ofthe MyoD1 Genein the Clone13 Cells
The cells were grown to confluence and maintained for up
to 8 wk after confluence to provide optimal conditions for
myotube formation. RNA was isolated from these cells and
analyzed by Northern blotting, which showed that the exoge-
nous 2.4-kb MyoD1 mRNA was not expressed in HaCaT or
Vec-2 but was strongly expressed in clone-6 and clone-13
cells (Fig. 1 B) . The number of MyoD1 expressing cells was
determined by immunofluorescence with an antibody against
MyoDl. 50-70% of the clone-13 cells expressed the gene at
the protein level (Fig. 1 C) while Vec-2 cells were com-
pletely negative (Fig. 1 D).
InfluenceoftheMyoD1 Gene on CellPhenotype
In Vitro
All transfected clones largely resembled the polygonal,
tightly packed parental HaCaT cells in confluent cultures
(Fig. 2 A). Islands of cells with more elongated mesen-
chymal morphology developed in postconfluent cultures of
clone-13 (Fig. 2 B) and large multinucleated cells which
strongly resembled myotubes couldbe detected in densecul-
tures kept for more than 3 wk after confluence. No such cells
were seen in cultures of HaCaT or Vec-2 cells.
Cultures were incubated with antibodies against the mus-
cle contractile protein myosin, and two intermediate filament
proteins, desmin and vimentin, found in muscle or mesen-
chymal cells, to determine whether MyoD1 was able to in-
duce the expression of these proteins. Neither HaCaT nor
Vec-2 cells expressed any of these markers. Clone-13 cells,
on the other hand, expressed myosin (Fig. 2 C) and desmin
(Fig. 2, D and E) in 1-10% of the cells. Expression was
highest after 2-4 mo postconfluence and here it was found
to be present in myotube-like (Fig. 2 D) as well as small
epithelial-like cells (Fig. 2 E). This long interval for maxi-
mal myogenic differentiation clearly differed from that ob-
served with other cell types. Vimentin, on the other hand,
was regulated differently since this protein was expressed in
-40% ofclone-13 cells immediately after plating (Fig. 2 E)
and the expression level did not increase further in post-
1259Figure 1 . (A) Verification of integration ofthe mouseMyoDl gene into the HaCaT genome. HaCaT, Vec-2 (control), and clone-6 and clone-
13 (both MyoDl containing) cell DNAs (10 Fig) were digested to completion with EcoRl, electrophoresed on agarose gels, and transferred
to nylon membrane. The Southern blot was hybridized with 32P-labeled MyoDl cDNA probe . The 1.8-kb band represents the MyoDl in-
sert while the 6.8-kb band represents the resident human homologue . (B-D) Expression of myogenic determination genes . (B) Northern
blot analysis (20 pg) of total RNA isolated from postconfluent cultures (>6 wk, maximal myotube formation) of HaCaT, Vec-2, clone-6,
and clone-13 cells after hybridization with 32p-labeled MyoDl probe. MyoDl was not present in HaCaT and Vec-2 cells but expressed in
clone-6 and clone-13 cells . (Bottom panel) Same blot hybridized with glyceraldehyde-3 phosphate-dehydrogenase (GADPH) indicating the
concentrations of loaded RNA . (C and D) Immunofluorescence micrographs after labeling with an antiserum against MyoD1 of cultures
from clone-13 (C) and Vec-2 cells (D) . Bar, 25 Am .
confluent cultures. The epithelial nature of the vimentin-
positive clone-13 cells was demonstrated by double labeling
using a mouse monoclonal vimentin and a guinea pig poly-
clonal pankeratin antiserum . All vimentin-positive cells
were also positive for keratin, but as expected, not all cells
positive for keratin expressed vimentin (Fig . 2, E and F) .
Epidermal Characteristics
Keratin profiles were analyzed using antibodies specific for
the different keratins to determine whether the expression of
mesenchymal/myogenic markers abrogated the production
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of proteins characteristically present in the epidermal
HaCaT cells . Keratin 14, generally expressed in the basal
layer of the epidermis and characteristic for squamous
epithelia, was present in all HaCaT, Vec-2, and also clone-13
cells while Kl and K10, the differentiation-specific supra-
basal keratins, were only seen in a few scattered cells in con-
fluent cultures (Table I) . In addition to the epidermal kera-
tins, the HaCaT cells also express "simple epithelia" keratins
(K7, K8, K18, and K19) (see also Boukamp et al ., 1988 ; Ryle
et al ., 1989 ; Breitkreutz et al ., 1991) characteristic for non-
keratinizing epithelia (Moll et al ., 1982a) . This pattern re-
mained unchanged for Vec-2 cells while a slight shift was
1260Figure 2 . Phenotypic heterogeneity of theMyoDI transfected clone-13 cells in culture. (A and B) Phase contrast micrographs ofconfluent
cultures of clone-13 cells showingHaCaTlike morphology (A)andan island of elongated mesenchymal-like cells including multinucleated
cells reminiscent of myotubes (B) . (C-F) Immunofluorescence of myogenic differentiation products : Myosin (C) ; desmin (D and E),
demonstrating that myotube- (D) as well as epithelial-like (E) cells express themyogenic marker. (F and G) Double fluorescence showing
that vimentin (F) is expressed in -40% ofthe cells that are all positive when apankeratin antiserum(G) is used . Theimmunofluorescence
was performed on fixed and permeabilized cells . Bars : (A and B) 100 Am; (C-F) 25 jm .
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126 1TableI. ExpressionofKeratins in HaCaTand
Transfected Cells In Vitro
* Only single cells positive.
seen in cultures ofclone-13 cellswhere K8 was no longer de-
tected, suggesting a rather moderate influence on keratin ex-
pression by the transfected MyoD1 gene.
Differentiation CharacteristicsIn Vivo
Complete epidermal differentiation is manifestedby the for-
mation of a multilayered well-organized tissue (stratified
squamous epithelium) as well as the expression and correct
spatial distribution of the different keratinization associated
proteins. In general, this process remains incomplete under
conventional culture conditions (Holbrook and Hennings,
1983; Breitkreutz et al., 1984) and thus, changes in morpho-
genesis are particularly difficult to assess in vitro. We there-
fore used a surface transplantation assay (Fusenig et al.,
1983; Boukamp et al., 1990x) to analyze whether the capac-
ity for tissue reconstitution of HaCaTcells under in vivo con-
ditions was affected by expression of the MyoD1 gene.
When HaCaT cellswere transplanted onto nude mice, they
showed epidermal tissue architecture and the expression and
correct spatial distribution of typical differentiation markers,
thus largely resembling transplants of normal human ker-
atinocytes (Boukamp et al., 1988, 1990x; Breitkreutz et al.,
1991) . The control cells (Vec-2) were not altered in their
differentiation capacity (not shown) and clone-13 cells also
formed a similarly well-structured epidermis-like surface
epithelium with a distinct stratum granulosum and aparaker-
atotic, often massive stratum corneum within 3-4 wk after
transplantation (Fig. 3 A). Typical epidermal differentiation
markers were expressed and orderly distributed. Keratins Kl
and K10 were present in all suprabasal layers (Fig. 3 B),
filaggrin was expressed in the uppermost living cell layers
just underneaththe stratum corneum (Fig. 3 C), and an anti-
body to involucrin strongly stained the upper flattened living
cell layers (Fig. 3 D).
Sections of the transplants were also labeled with antibod-
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ies against the myogenic differentiation products but were
negative for desmin and myosin (not shown) . Vimentin, on
the other hand, was expressed in transplants of clone-13 cells
(Fig. 3 E) while it was never seen in transplants of HaCaT
or Vec-2 cells. Interestingly, the vimentin-positive cells were
located in the basal layer of the epithelium. This restriction
to the basal layer might indicate a controlled expression of
vimentin in vivo. Thus, MyoD1 did not interfere with epider-
mal morphogenesis or the expression and correct spatial dis-
tribution of the differentiation markers despite the induced
expression of vimentin in vivo.
Derivation ofSubclonesfrom Clone13by
5-aza-2'-deoxycytidine Treatment
The myogenic conversion of MyoDI-transfected osteosar-
coma cells can be potentiated by 5-aza-2'-deoxycytidine (5-
aza-CdR) treatment (Chen and Jones, 1990). To determine
the effect of additional 5-aza-CdR on the human epidermal
cells we treated HaCaT, Vec-2, and the MyoD1 transfected
clone-13 cells with the hypomethylating drug.
Treatment ofcontrol cellswith 5-aza-CdR (HaCaTaza and
Vec-2-aza) did not lead to obvious phenotypicchanges. The
cells maintained their epithelial morphology in sparse and
dense cultures. Furthermore, they neither expressed myo-
genic markers nor did they lose epidermal markers (not
shown). In the 5-aza-CdR treated clone-13 cultures (clone-
13aza) the number of MyoDI expressing cells remained vir-
tually unchanged, but the number of multinucleated cells
resembling myotubes and mononucleated cells resembling
spindle-shaped refractile myoblasts became more frequent in
postconfluent cultures. Also, the number ofmyosin and des-
min positive cells increased from ti5 to 15 % . The kera-
tin pattern, on the other hand, was not affected (data not
shown) .
Significant changes were, however, seen when the cells
were transplanted onto nude mice. The control cells(HaCaT
aza and Vec-2aza) formed largely normal epidermis-like sur-
face epithelia (not shown), whereas the clone-13aza cells
formed a multilayered but morphologically disorganized and
noncornified epithelium (Fig. 3 F). Surprisingly, when this
epithelium was examined immunohistochemically, even
markers of late stages in epidermal differentiation were ex-
pressed. Keratins Kl and K10 were present in nearly all
suprabasal layers (Fig. 3 G) and filaggrin was localized pre-
dominantly in the uppermost cells (Fig. 3 H) . Only involu-
crin occasionally showed an abnormal patchy distribution
(Fig. 3 I) . MyoDl positive nuclei were irregularly dis-
tributed over the epithelium similarly as in transplants of
clone-13 cells (data not shown). Thus, by 5-aza-CdR treat-
Figure 3. In vivo growth and differentiation behavior after transplantationas organotypic cultures (on a collagen gel) onto the muscle fascia
of nude mice. The transplants were removed after27 d, snap frozen, and cryostat sectioned. Transplants of (A-E) clone-13 cells and (F-J)
clone-13aza cells. (A) Clone-13 cells formed a well-differentiated epidermis-like epithelium with distinct stratum granulosum (arrows) and
massive stratum corneum. Comparable sections were labeled with antibodies against the differentiation-specific epidermal keratin Kl, ex-
pressed in all subrabasal layers (B); filaggrin, the matrix component of the keratohyalin granules, labeling the stratum granulosum (C,
seearrows) and involucrin, one ofthe precursor proteins of the comified envelopes, giving rise to a membrane bound staining ofthe upper-
most layers of the epithelium (D). Vimentin, the only mesenchymal/myogenic differentiation product present in vivo was restricted to the
basal layer of the epithelium ofclone-13 cells (E, see arrowheads). (F-J) Transplants of clone-13aza cells: histological section of the mor-
phologically rather uniform epithelium with no indications of typical epidermal strata or cornification (F); similar section labeled with
antisera against Kl. As with clone-13 cell all suprabasal layers were positive (G); and the uppermost cells stained positive for filaggrin
(arrows) (H). Involucrin occasionally showed an irregular distribution (1). Here too vimentin remained restricted to the basal layer of
the epithelium (J, see arrowheads). Bar, 25 um.
Keratin N* HaCaT Vec-2 Clone-13
14 Epidermal + + +
1+10(11), Keratins (+)* (+)* (+)*
7 + + +
8 Simple Epithelia + + -
18 Keratins + + +
19 + + +Figure 4 . In vitro characteristics of the mesenchymal-like DTHMZ cells . (A) Phase contrast micrograph of the DTHMZ cells showing
alteredmorphology. (B and C) Immunofluorescence micrographs ofculturedDTHMZ cells labeled with antisera against MyoDI (B) and
vimentin (C) . In both cases 100% of cells are positive . Bars : (A) 100 /Am; (B and C) 25 pm .
ment of the MyoD1 transfected clone-13 cells, morphogene-
sis was disturbed while the expression of typical epidermal
differentiation products remained unaffected . This showed
that the processes ofhisto- and cytodifferentiation can be un-
coupled and might therefore be regulated independently.
To determine whether the altered histogenesis was as-
sociated with the expression of myogenic differentiation
products, sections were labeled with antibodies against myo-
sin, desmin, and vimentin . Similar to the transplants of the
untreated clone-13 cells myosin and desmin were not ex-
pressed in transplants of clone-13aza cells (not shown) and
vimentin still remained restricted to cells of the basal cell
layer (Fig . 3 J) .
Table H. Comparison ofEpidermal and
Nonepidermal Differentiation Markers Between
Clone-13aza and DTHMZ Cells
* Only single cells positive.
Density dependent .
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Mesenchymal Cell-likeSubpopulation Differentially
T}psinizedHaCaT-MyoDl 5-aza-CdR Reated Cells
During trypsinization it was observed that a fraction of cells
detached from the plasticmuch more rapidly than the gener-
ally strongly adhesive HaCaTlike cells in clone-13aza cul-
tures . We cannot exclude that a small number of these cells
was already present in clone-13 cultures but they obviously
could not be detected . Accordingly, cells with a comparable
trypsinization behavior were never observed in cultures of
HaCaTaza or Vec-2aza cells nor during the numerous clon-
ing experiments using HaCaT cells of different passage
levels . Thus, by short term trypsin treatment of clone-13aza
cultures a cell fraction was obtained with clearly altered
adhesion properties .
Differentiation Properties In Vitro
These differentially trypsinized HaCaTMyoDl 5-aza-CdR
treated cells (DTHMZ)1 cytologically no longer resembled
HaCaT cells (Fig . 4 A) . Moreover, 100% of the cells were
now positive for MyoDI (Fig . 4 B) and vimentin (Fig . 4 C
and Table II) . Also MyoDI expression at the RNA level was
increased in the DTHMZ compared to the clone-13 and
clone-13aza cells (Fig. 5 A), thus correlating well with the
immunofluorescence data . A human rhabdomyosarcoma
cell line (RD) was used as a positive control .
The effect ofMyoD1 expression of induction on other myo-
genic determination genes was measured next .A probe for
Myf3, thehumanhomolog ofthemouseMyoD1 gene (Braun
et al., 1990), was used to determine whether expression of
the endogenous human gene was induced by the transfected
mouse gene . Myf3 does not cross hybridize with MyoDl un-
der stringent hybridization conditions and this probe can
1 . Abbreviations used in this paper : DTHMZ, differentially trypsinized
HaCaTMyoDl 5-aza-CdR treated cells ; RD, human rhabdomyosarcoma
cell line .
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Differentiation markers Clone-13aza DTHMZ
Vimentin myogenic =40% 100%
Myosin differentiation =15% =30%
Desmin markers =15% =30%
K14 epidermal +
K1/10 keratins (+)*
K8
K7 simple epithelia + +
K19 keratins + +
K18 + (+)t
Desmoplakin desmosomal +
Plakoglobin proteins +
Desmoglein +
GP90 surface + -
GP130 1 glycoproteins - +Figure 5. Myogenic properties of theDTHMZ cells . (A) Northern blot analysis of total RNA isolated from postconfluent cultures of clone-
13, clone-1 3aza, DTHMZ, and a human rhabdomyosarcoma cell line (RD), used as a positive control for all probes . The blots were hybrid-
ized with 31P-labeled MyoDl, Myf3 (the human homolog of MyoDl), myogenin, and GADPH probes ; the latter as control for the concen-
trations of loaded RNA . MyoD1 was expressed in clone-13 and clone-13aza cells and strongly increased in DTHMZ cells . Myf3 could
only be detected in DTHMZ cell while myogenin, clearly expressed in DTHMZ cells also showed a faint expression in clone-13aza cells .
(B) Immunofluorescence micrographs ofDTHMZ cultures where -30% of the cells are labeled with an antibody against desmin ; upper
part shows a single large cell and lower part small myoblast-like cells that all stain positive for desmin . Bar, 25 Am .
therefore be used to assay for the expression of the endoge-
nous human MyoD gene. The RD cells, used as a control,
were positive for Myf3 expression as reported previously
(Hiti et al., 1989) (Fig . 5 A) . The Myf3 signal was absent
in clone-13 and clone-13aza cells but was present inDTHMZ
cells, demonstrating positive autoregulation by MyoD1 .
We further assayed for the expression of myogenin, since
previous studies have shown that this gene is associated with
muscle cells and a positive regulatory loop has been de-
scribed between MyoDI and myogenin (Thayer et al ., 1989 ;
Chen and Jones, 1990) . The control RD cells and the
DTHMZ cells were clearly positive for myogenin expression
and a faint signal was sometimes seen for the clone-13aza
cells while the clone-13 cells were always negative (Fig . 5 A) .
Expression of two other myogenic determination genes,
Myf5 (Braun et al ., 1989) and herculin (Miner and Wold,
1990) was not detectable upon Northern blot analysis (data
not shown) .
To determine whether the increase inMyoD1 as well as ex-
pression of the other myogenic determination genes cor-
related with increased myogenic differentiation, cultures of
DTHMZ cells were stained with myosin and desmin antibod-
ies (Fig . 5B) . In both cases thenumber ofpositive myotube-
and small epithelial-like cells had increased from -15% for
clone-13aza to -30% for DTHMZ cells (see Table II) cor-
relating with a comparable increase in MyoD1 positive cells .
On the other hand, the DTHMZ cells, unlike their progen-
itor clone-13aza cells, no longer expressed any ofthe epider-
mal keratins (basal K14 and suprabasal Kl and K10 ; Table
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II) . Among the "simple epithelia keratins K8 was absent, as
already seen in cultures of clone-13aza cells, while K7 and
K19 were maintained and gave rise to a filamentous pattern
in most cells (not shown) . K18, on the other hand, was ex-
pressed in a density dependent way. In subconfluent cultures
10-30% ofthe cells were positive, whereas at confluency all
cells were negative, indicating a mode ofregulation indepen-
dent from that of K7 and K19.
Further significant changes were seen in the expression
of cell surface markers including desmosomal proteins
(plakoglobin, desmoglein, anddesmoplakin) which are com-
ponents of the typical epidermal junctions (desmosomes),
being expressed in clone-13aza cells but not in the DTHMZ
cells (Table II) . The distribution of two cell surface proteins,
GP90 and GP130, was also analyzed . Generally, the expres-
sion of the 90-kd glycoprotein is significantly increased in
transformed human epithelial cell lines (Klein, C. E ., B .
Hartmann, L . Weber, and L . J . Old . 1989 . Immunobiology.
178:36[Abstr .]) while the 130-kd glycoprotein is not ex-
pressed in normal epidermis but at high levels in capillary
endothelial, smooth muscle and myoepithelial cells (Klein et
al ., 1988) . While clone-13aza cells were strongly positive
for GP90 and negative for GP130 as found for HaCaT cells
(not shown) the reverse was seen for the DTHMZ cells,
GP90 being negative and GP130 expressed in all cells (see
Table II) . Thus, the complete loss of epidermal markers in-
cluding morphology, epidermal keratins, and desmosomal
proteins), change in cell surface glycoprotein expression, ex-
pression of mesenchymal cytoskeletal proteins (vimentin
1265Figure 6 . In vivo characteristics of the
DTHMZ cells . (A) Histology of a 6-d-old
transplant . Note the inability to stratify.
(B-E) Immunofluorescence of the single-
layered epithelium labeled with antisera
against vimentin (B) and pankeratin (C)
analyzed by double labeling show that all
cells expressed both proteins ; most cells
are also positive for desmin (D) but nega-
tive for myosin (E) . Bar, 25 lm .Figure 7 . DNA fingerprint . Southern blot analysis of DNA from
DTHMZ and HaCaT cells hybridized with the 32P-labeled hyper-
variable minisatellite probe 33.15. The qualitatively identical pat-
tern unequivocally demonstrates the HaCaT origin .
and desmin), the muscle protein myosin and additional myo-
genic determination genes (myf3 and myogenin) strongly ar-
gue for a shift from a clearly epidermal to a mesenchymal/
myogenic phenotype rather than mere abrogation of epider-
mal differentiation .
Differentiation Characteristics oftheDTHMZCells
In lrvo
The DTHMZ cells did not stratify when transplanted onto
nude mice but remained as a monolayer of flat elongated
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cells even after 27 d in vivo (Fig . 6 A) . These cells reacted
with antibodies against pankeratin and vimentin by double
inimunofluorescence (Fig. 6, B and C) . Additionally, desmin
was expressed (Fig. 6D) while myosin could not be detected
in these transplants (Fig . 6E) . Thus, also the in vivo growth
behavior and expression pattern in the transplants support
the hypothesis that complex changes were induced by the
different treatments giving rise to "transdifferentiation» from
the epidermal HaCaT cells to the mesenchymal/myogenic
DTHMZ cells .
ProofforDescentofDTHMZfromHaCaTCells
The DTHMZ cells were analyzed cytogenetically and by
DNA fingerprinting to ensure that they were derived from
the HaCaT cell line and to exclude cross-contamination with
other mesenchymal cell lines . Firstly, the marker chromo-
somes defining the monoclonal origin of the epidermal
HaCaT cells were still present in 100% of the DTHMZ cells
(Pascheberg, U., personal communication ; see Boukamp et
al ., 1988) . Secondly, also the quantitatively identical DNA
fingerprint pattern (Fig . 7) unequivocally demonstrated the
common origin of the HaCaT and DTHMZ cells . Thus, by
transfection of the MyoDI gene into human keratinocytes
followed by 5-aza-CdR treatment and further selection for
decreased attachment to the substratum, a phenotypically
highly divergent cell population had developed which could,
however, clearly be identified as a HaCaT descendant .
Discussion
"MyogenicConversion"byMyoDI Transfection
Our studies demonstrate that theMyoDI gene can induce the
expression ofmyogenic differentiation products in the human
epidermal HaCaT cells. The data are in line with findings by
Blau et al . (1985) demonstrating that fusion of amouse mus-
cle cell line with anumber ofnormal human cells, including
keratinocytes, leads to the expression of human muscle
markers . Similarly, Choi et al . (1990) could show that a
number of different nontransformed cells, including retinal
pigmented epithelial cells, can convert into striated mono-
nucleated myoblasts and multinucleated myotubes after
MyoDI infection . Other epithelial cells such as HeLa, which
have lost their differentiation capacity, appear to be refrac-
tory to myogenic conversion (Blau et al ., 1985 ; Weintraub
et al., 1989) . These and our data strongly favor the hypoth-
esis that cells which have maintained their potential to dif-
ferentiate can be forced to myogenic differentiation by the
MyoDI gene . This might indicate that endogeneous differen-
tiation related genes (gene products) are involved or are
required to cooperate with MyoDI to activate myogenic dif-
ferentiation in nonmuscle cells . The level of myogenic con-
version was low in the HaCaT cells compared with 1 Tl/2
and other cell lines . This might well be because of the fact
that the epidermal cells are less predisposed towards myo-
genesis as discussed earlier for human osteoblastic TE85
cells (Chen andJones, 1990) . Similarly, forthe human/mouse
heterokaryons it was found thattissue derivationand possibly
embryonic origin had marked effects on the kinetics and ulti-
mate frequency ofexpression ofmuscle markers (Blau et al .,
1985) .
Two mechanisms have been proposed for the induction of
1267myogenic differentiation products, (a) direct activation by
binding of MyoDI to a consensus sequence (CANNTO) re-
ferred to as an E box (for review see Emerson, 1990), and
(b) indirect activation for those genes lacking the consensus
sequence. Depending on the respective activating mecha-
nism one might expect a higher or lower level of expression
of myogenic differentiation markers in nonmuscle cells. My-
osin heavy chains, for example, have to be activated in-
directly since they do not contain E boxes within their cis-
regulatory regions (Bouvagnet et al., 1987) . Expression of
this gene was low (1-10 %) in the clone-13 cellsand this might
indicate an inefficient transactivating mechanism in the non-
muscle cells. Vimentin, on the other hand, a cytoskeletal
protein, not exclusively expressed in myogenic cells but as-
sociated with mesenchyme-derived cells, was expressed in
-40 % of the MyoD1 transfected cells. This high percentage
may be due to a direct regulation of vimentin by MyoDI es-
pecially since vimentin obviously contains a CANNTG-like
sequence in its 5' regulatory region.
Vimentin is occasionally expressed in epithelial cells ei-
ther in normal tissue during embryogenic development (Franke
et al., 1982; Holth6fer et al., 1983; LeDouarin et al., 1984;
Lehtonen et al ., 1985; Paranko and Virtanen, 1986)or after
oncogenic transformation (Franke et al., 1979 ; Fusenig et
al., 1982; Azumi and Battifora, 1987; Raymond and Leong,
1989 and references therein; Domagala et al., 1990). Nor-
mal humankeratinocytes apparently express vimentin at cer-
tain stages of growth in vitro (van Muijen et al ., 1987a;
Smola, H., G. Thiek6tter, D. Breitkreutz, and N. E. Fuse-
nig, manuscript in preparation) suggesting that the gene can
be activated in epithelial cells by several factors. However,
the HaCaT keratinocyte line has not been found to express
vimentin under a variety of growth conditions in vitro and
in vivo even aftertumorigenic conversionfollowing transfec-
tion with the Harvey-ras oncogene (Boukamp, P., unpub-
lished observation) . Thus, in the present case, vimentin in-
duction was probably a direct consequence of MyoDI
transfection.
Stability ofthe Inherent Epidermal Phenotype
The HaCaT cells showed only minor changes in the expres-
sion of epidermal differentiation after MyoDl transfection .
The keratins, classifiedon the basis of molecular weights and
charges (Moll et al., 1982a), show a characteristic pattern
of expression for a particular cell type and tissue (Franke et
al., 1984 ; Sun et al., 1984). The MyoDl transfected clone-13
cells maintained all typical HaCaT keratins analyzed (epi-
dermal keratins Kl, K10, K14, and "simple epithelia' kera-
tins K7, K18, and K19) (see also Ryle et al., 1989; Breit-
kreutz et al., 1991) with the exception of K8. The stability
of the epidermal differentiation pattern in clone-13 cells was
even more apparent under more physiological conditions in
vivo. Despite thephenotypic changes seen in vitro, a well or-
ganized and differentiated epidermis-like epithelium, virtu-
ally indistinguishable from that of control (HaCaT and Vec-
2) cells, was formed by the clone-13 cells. The expression
and localization ofthe major differentiation products such as
the keratins K1 and K10, filaggrin and involucrin were nor-
mal in concert with a regular tissue architecture. The only
differenceobservedbetweenclone-13 and theHaCaTorVec-2
transplants was the additional expression of vimentin while
myosin or desmin were not detected . However, unlike the
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situation in vitro where a high percentage of cells were vi-
mentin-positive only a minor fraction of cells was positive
forvimentin in transplantsandthese were generally restricted
to the basal layer ofthe epithelium. These findings may indi-
cate that coexpression of the differentiation specific keratins
Kl, K10, and vimentin is not compatible. Alternatively, vi-
mentin couldbe masked (as known for K14) when cells move
upward and differentiate, no longer being recognized by the
antibody.
It also cannot be excluded that in vitro the growth and
differentiation pathway is regulated differently from that in
vivo since one important aspect is that the cells in vitro are
not subject to the control of systemic factors or factors de-
rived from the underlying mesenchyme. Our previous
studies have clearly shown that complete epidermal differen-
tiation including the status of tissue homeostasis is only
obtained under mesenchmal influence (Boukamp et al.,
1990a; Klingel et al., 1990; Fusenig et al., 1991; Smola, H.,
G. Thiek6tter, D. Breitkreutz, and N. E. Fusenig, manu-
script submitted for publication) and that in surface trans-
plants the whole process only takes one to two weeks. Thus,
it is very likely that in vivo (under the control of the mes-
enchyme) epidermal differentiation predominates while the
myogenic differentiation pathway is not necessarily favored
in this environment. Accordingly, the time span for a given
cell in vivo (passing through the different cell layers) might
be too short to express myogenic differentiation markers
(others than vimentin) because of their long latency period
already observed in vitro. Alternatively, myogenic differenti-
ation might be completely downregulated under the in vivo
conditions. Thus, the alterations after MyoDI transfection
seen under in vitro conditions obviously had no major effects
on epidermal tissue morphogenesis and the correct spatial
distribution of the epidermal differentiation markers in vivo.
5Azacytidine Treatment Causes Loss of
Tïssue Morphogenesis
In a second step we tried to potentiate the MyoDl activity
in clone-13 cells by treatment with the hypomethylating
agent 5-aza-CdR. This was done because the frequency of
myogenic conversionin transfected osteosarcoma cellscould
be increased by such treatment (Chen and Jones, 1990).
5-Aza-CdR treatment caused a substantial change in the
differentiation behavior of clone-13 cells in vivo. Although
the cells were still able to stratify, a morphologically un-
structured epithelium was formed with no indications oftyp-
ical epidermal cell layers including cornification. Neverthe-
less, this epithelium still expressed the major differentiation
products Kl and K10, filaggrin, and involucrin.
This morphological alteration was particularly striking
since neither long-term passaging, tumorigenic conversion
(Boukamp et al ., 1990b), nor 5-aza-CdR treatment by itself
(HaCaTaza, Vec-2aza) interfered with the potential of
HaCaT cells to develop a well-organized epidermis after
transplantation . Thus, 5-aza-CdR treatment of MyoD1
transfectants (clone-13) resulted in a loss of morphogenic
potential without blocking the expression of differentiation
markers. This demonstrates that histo- and cytodifferentia-
tion can be dissociated under certain conditions.
This dissociation can also be seen in tumors or tumor-
derived cell lines since we had demonstrated earlier that a
cell line established from a mouse skin carcinoma failed to
1268express Kl and K10 in transplants although these cells
formed a morphologically keratinizing surface epithelium
(Breitkreutz et al., 1986). Another example for dissociation
of histo- and cytodifferentiation is the embryonic develop-
ment of the epidermis. During embryogenesis the human
epidermis develops from a two-layered epithelium express-
ing the "simple epithelia keratins K8 and K18 (Moll et al.,
1982b) and the cells start to stratify and express epidermal
keratins as soon as a three-layered epithelium has formed
(week 10). The switch from simple epithelia to epidermal
keratins therefore appears at a "transitional stage" where
epidermal morphogenesis is still incomplete. The epithelium
obtained from the 5-aza-CdR treated clone-13 cells seems to
resemble the transitional phase during embryogenic devel-
opment.
Prendergast and Ziff (1991) have very recently shown that
binding of the basic motifof c-myc to DNA is methylation
sensitive in that binding is specific for unmethylated sites.
MyoDI is known to contain a region with high sequence ho-
mology to the c-myc family protein as well as a highly basic
region (Lassar et al., 1989) so that binding of MyoD might
be preventedby methylation in an analogous fashion to c-myc.
Thus, methylation might be one possible mechanism to
stabilize the final state ofthe well stratified adult epidermis.
Since hypomethylation by itself was insufficient to destroy
morphogenesis and control cells (HaCaT or Vec-2 cells
treated with 5-aza-CdR) still formed a well-structured and
differentiated epidermis-like epithelium, additional factors/
gene products have to be required in early development that
are obviously inactive in the adult epidermis. Whether MyoD-
or generally Helix-Loop-Helix-like genes are involved will
be studied.
Mesenchymal-like Subpopulation
(DTHMZ): "Transdiferentiation"
The DTHMZsubpopulation isolated from clone-13aza cells,
i.e., derived from a typical epidermal cell, had lost its epi-
thelial morphology, changed the pattern of intermediate fila-
ment protein and cell surface glycoprotein expression, and
was no longer able to stratify in vivo, associated with a lack
of desmosomal proteins and expression of additional myo-
genic determination genes. However, its identity with the
epidermal HaCaT cells was proven by cytogenetic analysis
and DNA fingerprinting.
The fact that these cells were obtained by selection for re-
duced adhesion to plastic by short trypsinization strongly ar-
gues for changes in the expression of adhesion molecules.
One possible candidate is gp90, a glycoprotein selectively
expressed in adherently growing transformed cells (Klein,
C. E., B. Hartmann, L. Weber, and L. J. Old. 1989. Im-
munobiology. 178 :36[Abstr.]) and induced in suspension
cultures of neuroblastoma cellsselected for substrate adher-
ence (Rettig et al ., 1987). The marked decrease in adhesion
by the DTHMZ cells was correlated with the loss ofthis pro-
tein . DTHMZ cells had also gained the expression ofanother
surface glycoprotein, gpl30, which is present at high levels
in mesenchymal cells ofvarious origins (Klein et al., 1988),
but generally absent in normal epidermis and was not detect-
able in the parental clone-13aza cells. Together with the other
findings, this switch in surface glycoproteins strongly argues
for a "transdifferentiation" process from an epidermal to a
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mesenchymal/myogenic phenotype rather than mere down-
regulation of some epidermal traits in the DTHMZ cells.
Support for this hypothesis was also evident from the
Northern blot analysis. As mentioned earlier, Thayer et al.
(1989) have shown that MyoD1 and myogenin appear to
function in positive autoregulatory loops which include acti-
vation of the endogenous MyoD1 by the transfected MyoD1
c-DNA. This transactivation of the humanhomologue Myf3
(Braun et al., 1989) by the mouse MyoDI as well as induc-
tion of myogenin in the DTHMZ cells is in good agreement
with theirimproved myogenic potential. Expressionof Myf5
and herculin, two other myogenic determination genes
(Braun et al., 1989; Miner and Wold, 1990), was not de-
tected in the DTHMZ cells. There is, however, evidence that
MyoDI and Myf5 are usually not coexpressed and that her-
culin (or Mrf4) is not expressed in most cultured myogenic
cell lines (for review see Emerson, 1990). The expression
of these two genes might be regulated differently as com-
pared to the expression of MyoDI (Thayer and Weintraub,
1990) and therefore the lack of expression in the DTHMZ
cells could be because of more general phenomena rather
than being specific for the epidermal origin of the cells.
The mesenchymal/myogenic nature of the DTHMZ cells
was further supported by the transplantation studies. The
DTHMZ cells were no longer able to stratify, but remained
as a monolayer of flat elongated cells throughout the whole
observation period unlike all other epithelial cells tested in
our transplantation system. Even undifferentiated HeLa and
hybrid cells derived from the fusion of HeLa with normal
fibroblasts (Stanbridge et al., 1982) maintained the propen-
sity to form a multilayered tissue (Bosch et al ., 1990) . Thus,
the loss of stratification in the DTHMZ cells and the expres-
sion of vimentin and desmin in these transplants strongly
argues for major phenotypic changes in this particular sub-
fraction of cells. Because these cells are, however, true de-
rivatives of the epidermal HaCaT cells, they might provide
a valuable tool to gain a closer view of the regulatory mecha-
nisms involved in stratification ofepidermal cellsand repres-
sion of stratification in mesenchymal-type cells.
The preserved expression ofthe "simple epithelia"keratins
by the DTHMZcells is more than a remnant ofthe epithelial
origin since these keratins are often found to be present in
nonepithelial cells (Knapp et al., 1989; and references
therein). For example, K8 and K18 were shown to be coex-
pressed with desmin in developing myocardial cells of some
vertebrate species (Kuruc and Franke, 1988) and keratin 19
was found to be present in smooth muscle cells in vitro and
in vivo (Gown et al., 1988), indicating that coexpression of
different types ofintermediate filaments (keratins, vimentin,
and desmin) is a more general phenomenon in nonepithelial
cells; especially more than previously realized in fetal tis-
sues (van Muijen et al., 1987b) . Thus, the maintained ex-
pression of the keratins K7, K18, and K19 is clearly com-
patible with a fully differentiated mesenchymal/myogenic
phenotype and consequently also compatible with the trans-
differentiation process postulated for the DTHMZ cells.
In conclusion, our studies have shown that MyoDI can in-
duce the expression of muscle-specific gene products in the
epidermal HaCaT cells ,confirming earlier findings that
MyoDI can act as a master switch gene in differentiating
nonmyogenic cells. However, MyoDI by itself did not sig-
nificantly alter the epidermal differentiation characteristics
1269in vitro nor did it interfere with epidermal morphogenesis in
vivo. By additional 5-aza-CdR treatment morphogenesis
(histodifferentiation) and the expression of specific epider-
mal differentiation products (cytodifferentiation) could be
dissociated suggesting at least two independent modes of
regulation . After both MyoD1 transfection and 5-aza-CdR
treatment and selection for reduced adhesion to the plastic
substratum, a subpopulation was derived which had lost the
epidermal characteristics and had acquired a mesenchymal-
cell phenotype. Thus, these studies (a) underlinethe stability
of the inherent epidermal phenotype and (b) also demon-
strate processes leading to transdifferentiation in somatic
cells (derived from adult tissue) in culture.
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